{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:03:12Z","timestamp":1790859792666,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Shenzhen Medical Research Fund","award":["C2501002"],"award-info":[{"award-number":["C2501002"]}]},{"name":"The Shenzhen Science and Technology Program","award":["JCYJ20240813150436048"],"award-info":[{"award-number":["JCYJ20240813150436048"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06226-8","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:45:48Z","timestamp":1790858748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epiregulin Mitigates Type 2 Diabetes-associated Cognitive Dysfunction by Inhibiting Hippocampal Neuronal Ferroptosis via the Nrf2 Pathway"],"prefix":"10.1007","volume":"63","author":[{"given":"Zhen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiahong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"6226_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/NDT.S189905","volume":"15","author":"O Albai","year":"2019","unstructured":"Albai O, Frandes M, Timar R, Roman D, Timar B (2019) Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment. Neuropsychiatr Dis Treat 15:167\u2013175","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"6226_CR2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archneur.64.4.570","volume":"64","author":"JA Luchsinger","year":"2007","unstructured":"Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R (2007) Relation of diabetes to mild cognitive impairment. Arch Neurol 64(4):570\u2013575","journal-title":"Arch Neurol"},{"issue":"1","key":"6226_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jalz.2013.01.001","volume":"10","author":"RO Roberts","year":"2014","unstructured":"Roberts RO, Knopman DS, Geda YE et al (2014) Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement 10(1):18\u201326","journal-title":"Alzheimers Dement"},{"issue":"6","key":"6226_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jdi.12087","volume":"4","author":"K Gudala","year":"2013","unstructured":"Gudala K, Bansal D, Schifano F, Bhansali A (2013) Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig 4(6):640\u2013650","journal-title":"J Diabetes Investig"},{"key":"6226_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","volume":"124","author":"J Zhang","year":"2017","unstructured":"Zhang J, Chen C, Hua S et al (2017) An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer\u2019s disease. Diabetes Res Clin Pract 124:41\u201347","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"6226_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2014-310095","volume":"87","author":"JQ Li","year":"2016","unstructured":"Li JQ, Tan L, Wang HF et al (2016) Risk factors for predicting progression from mild cognitive impairment to Alzheimer\u2019s disease: a systematic review and meta-analysis of cohort studies. J Neurol Neurosurg Psychiatry 87(5):476\u2013484","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"6226_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1176\/appi.ajp.2014.14070878","volume":"172","author":"C Cooper","year":"2015","unstructured":"Cooper C, Sommerlad A, Lyketsos CG, Livingston G (2015) Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry 172(4):323\u2013334","journal-title":"Am J Psychiatry"},{"issue":"1","key":"6226_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01727-3","volume":"17","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Wang W, Yang X et al (2025) Spontaneous brain activity in patients with type 2 diabetes: linking serum neuroproteins to cognitive ability. Diabetol Metab Syndr 17(1):174","journal-title":"Diabetol Metab Syndr"},{"issue":"13-15","key":"6226_CR9","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1089\/ars.2021.0233","volume":"37","author":"W Tang","year":"2022","unstructured":"Tang W, Li Y, He S et al (2022) Caveolin-1 alleviates diabetes-associated cognitive dysfunction through modulating neuronal ferroptosis-mediated mitochondrial homeostasis. Antioxid Redox Signal 37(13\u201315):867\u2013886","journal-title":"Antioxid Redox Signal"},{"key":"6226_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050733","author":"A Jehl","year":"2023","unstructured":"Jehl A, Conrad O, Burgy M et al (2023) Blocking EREG\/GPX4 sensitizes head and neck cancer to cetuximab through ferroptosis induction. Cells. https:\/\/doi.org\/10.3390\/cells12050733","journal-title":"Cells"},{"issue":"1","key":"6226_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7150\/ijbs.99423","volume":"21","author":"X Chen","year":"2025","unstructured":"Chen X, Chen X, Xie W et al (2025) BRAF-activated ARSI suppressed EREG-mediated ferroptosis to promote BRAFV600E (mutant) papillary thyroid carcinoma progression and sorafenib resistance. Int J Biol Sci 21(1):128\u2013142","journal-title":"Int J Biol Sci"},{"issue":"5","key":"6226_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade9585","volume":"9","author":"A Anandhan","year":"2023","unstructured":"Anandhan A, Dodson M, Shakya A et al (2023) NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci Adv 9(5):eade9585","journal-title":"Sci Adv"},{"issue":"1-2","key":"6226_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/ars.2006.8.43","volume":"8","author":"S Papaiahgari","year":"2006","unstructured":"Papaiahgari S, Zhang Q, Kleeberger SR, Cho HY, Reddy SP (2006) Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt\/ERK MAP kinase signaling in pulmonary epithelial cells. Antioxid Redox Signal 8(1\u20132):43\u201352","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"6226_CR14","first-page":"324","volume":"39","author":"F Xu","year":"2017","unstructured":"Xu F, Wang N, Li G, Guo W, Yang C, Liu D (2017) Establishment and assessment of mice models of type 2 diabetes mellitus. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 39(3):324\u2013329","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"8","key":"6226_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.braindev.2008.01.006","volume":"30","author":"N Tsuda","year":"2008","unstructured":"Tsuda N, Mizuno M, Yamanaka T, Komurasaki T, Yoshimoto M, Nawa H (2008) Common behavioral influences of the ErbB1 ligands transforming growth factor alpha and epiregulin administered to mouse neonates. Brain Dev 30(8):533\u2013543","journal-title":"Brain Dev"},{"key":"6226_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/neuro.07.004.2009","volume":"3","author":"HR Maei","year":"2009","unstructured":"Maei HR, Zaslavsky K, Teixeira CM, Frankland PW (2009) What is the most sensitive measure of water maze probe test performance? Front Integr Neurosci 3:4. https:\/\/doi.org\/10.3389\/neuro.07.004.2009","journal-title":"Front Integr Neurosci"},{"issue":"78","key":"6226_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq6691","volume":"7","author":"ID Odell","year":"2022","unstructured":"Odell ID, Steach H, Gauld SB et al (2022) Epiregulin is a dendritic cell-derived EGFR ligand that maintains skin and lung fibrosis. Sci Immunol 7(78):eabq6691","journal-title":"Sci Immunol"},{"key":"6226_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-024-00068-7","author":"P Cubillos","year":"2024","unstructured":"Cubillos P, Ditzer N, Kolodziejczyk A et al (2024) The growth factor EPIREGULIN promotes basal progenitor cell proliferation in the developing neocortex. EMBO J. https:\/\/doi.org\/10.1038\/s44318-024-00068-7","journal-title":"EMBO J"},{"issue":"2","key":"6226_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118280","volume":"10","author":"L Zhan","year":"2015","unstructured":"Zhan L, Zheng L, Hosoi T, Okuma Y, Nomura Y (2015) Stress-induced neuroprotective effects of epiregulin and amphiregulin. PLoS ONE 10(2):e0118280","journal-title":"PLoS ONE"},{"issue":"1","key":"6226_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0734-0","volume":"13","author":"XP Yang","year":"2016","unstructured":"Yang XP, Fu JY, Yang RC et al (2016) EGFR transactivation contributes to neuroinflammation in Streptococcus suis meningitis. J Neuroinflammation 13(1):274","journal-title":"J Neuroinflammation"},{"key":"6226_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.115031","volume":"383","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Guo H, Li Q et al (2025) TREM1 induces microglial ferroptosis through the PERK pathway in diabetic-associated cognitive impairment. Exp Neurol 383:115031","journal-title":"Exp Neurol"},{"issue":"33","key":"6226_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303809120","volume":"120","author":"A Nakano-Kobayashi","year":"2023","unstructured":"Nakano-Kobayashi A, Canela A, Yoshihara T, Hagiwara M (2023) Astrocyte-targeting therapy rescues cognitive impairment caused by neuroinflammation via the Nrf2 pathway. Proc Natl Acad Sci U S A 120(33):e2303809120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6226_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102201","volume":"94","author":"P Liu","year":"2024","unstructured":"Liu P, Zhang Z, Cai Y, Li Z, Zhou Q, Chen Q (2024) Ferroptosis: mechanisms and role in diabetes mellitus and its complications. Ageing Res Rev 94:102201","journal-title":"Ageing Res Rev"},{"issue":"3","key":"6226_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05708-0","volume":"14","author":"R Miao","year":"2023","unstructured":"Miao R, Fang X, Zhang Y, Wei J, Zhang Y, Tian J (2023) Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities. Cell Death Dis 14(3):186","journal-title":"Cell Death Dis"},{"key":"6226_CR25","doi-asserted-by":"publisher","unstructured":"Alghamdi H (2026) In vitro cell-line models of Alzheimer's disease: a systematic review and mechanism-based evidence map of induction paradigms, targeted mechanisms, and validation requirements. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2026.103322","DOI":"10.1016\/j.arr.2026.103322"},{"issue":"6","key":"6226_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-025-01145-0","volume":"24","author":"DD Zhang","year":"2025","unstructured":"Zhang DD (2025) Thirty years of NRF2: advances and therapeutic challenges. Nat Rev Drug Discov 24(6):421\u2013444","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"6226_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/ars.2014.5962","volume":"23","author":"M Xue","year":"2015","unstructured":"Xue M, Momiji H, Rabbani N et al (2015) Frequency modulated translocational oscillations of Nrf2 mediate the antioxidant response element cytoprotective transcriptional response. Antioxid Redox Signal 23(7):613\u2013629","journal-title":"Antioxid Redox Signal"},{"key":"6226_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106062","volume":"176","author":"MR Rizzo","year":"2022","unstructured":"Rizzo MR, Di Meo I, Polito R et al (2022) Cognitive impairment and type 2 diabetes mellitus: focus of SGLT2 inhibitors treatment. Pharmacol Res 176:106062","journal-title":"Pharmacol Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06226-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:45:49Z","timestamp":1790858749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06226-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6226"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06226-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"24 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was examined and approved by the Animal Care and Use Committee of The Seventh Affiliated Hospital, Sun Yat-sen University (SR20250101).","order":1,"name":"Ethics","label":"Ethical Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No artificial intelligence generated content tools were used in the preparation of this manuscript.","order":2,"name":"Ethics","label":"AI Declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"940"}}